MedPath

Pudendal Nerve Fluoroscopic Guided Pulsed Radiofrequency for Treatment of Superficial Dyspareunia

Not Applicable
Completed
Conditions
Superficial Dyspareunia
Interventions
Procedure: pudendal nerve pulsed radiofrequency
Registration Number
NCT04201041
Lead Sponsor
South Egypt Cancer Institute
Brief Summary

Superficial dyspareunia represents a major health problem especially for the newly wed couples. Pulsed radiofrequency for pudendal nerve is a non-neurolytic neuromodulatory method that is effective in relief of this type of pain. Objectives: to evaluate the efficacy of bilateral pudendal nerve fluoroscopic guided pulsed radiofrequency in treatment of intractable non-organic dyspareunia, and compare between trans-gluteal and transvaginal approaches regarding patient comfort and satisfaction.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • women aged between 16 and 46 years and from a near vicinity to our facility to make her available for follow-up
Exclusion Criteria
  • We had excluded women with any abnormality in the transvaginal US guided imagining, or those with any evidence of local gynecological abnormalities on examination. Meanwhile, we had excluded those women with infection at site of injection, coagulopathy or other bleeding diathesis, pre-existing neurologic deficit in the targeted region, those with history of chronic opioid use and women who refused to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
trans-gluteal approachpudendal nerve pulsed radiofrequencyreceived pudendal nerve pulsed radiofrequency through trans-gluteal approach
trans-vaginal approachpudendal nerve pulsed radiofrequencyreceived pudendal nerve pulsed radiofrequency through trans-vaginal approach
Primary Outcome Measures
NameTimeMethod
change in Numerical rating scalebaseline reading -1 day reading-3 days postoperative reading

0 no pain and 10 maximum pain

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

South Egypt Cancer Institute, Assiut University, Arab Republic of Egypt

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath